Mycobacterium tuberculosis complex enhances susceptibility of CD4 T cells to HIV through a TLR2-mediated pathway

PLoS ONE

Volumn 7, Issue 7, 2012, Pages

  Thayil, Seema M ^a   Ho, Ya Chi ^a   Bollinger, Robert C ^a   Blankson, Joel N ^a   Siliciano, Robert F ^a   Karakousis, Petros C ^a,b   Page, Kathleen R ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BCG VACCINE; CHEMOKINE RECEPTOR CCR5; CHEMOKINE RECEPTOR CXCR4; SMALL INTERFERING RNA; TOLL LIKE RECEPTOR 2; TLR2 PROTEIN, HUMAN;

ADULT; ARTICLE; BCG VACCINATION; CD4+ T LYMPHOCYTE; CELL STIMULATION; CONTROLLED STUDY; EX VIVO STUDY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION SENSITIVITY; MYCOBACTERIUM SMEGMATIS; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; RISK FACTOR; RNA INTERFERENCE; SIGNAL TRANSDUCTION; TUBERCULOSIS; VIRUS CELL INTERACTION; VIRUS STRAIN; DISEASE PREDISPOSITION; GENE EXPRESSION REGULATION; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNOLOGY; METABOLISM; MICROBIOLOGY; MYCOBACTERIUM BOVIS; PHYSIOLOGY; VIROLOGY;

MYCOBACTERIUM TUBERCULOSIS; MYCOBACTERIUM TUBERCULOSIS COMPLEX;

ADULT; CD4-POSITIVE T-LYMPHOCYTES; DISEASE SUSCEPTIBILITY; GENE EXPRESSION REGULATION; HIV-1; HUMANS; MYCOBACTERIUM BOVIS; MYCOBACTERIUM TUBERCULOSIS; TOLL-LIKE RECEPTOR 2; YOUNG ADULT;

EID: 84864239263     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0041093     Document Type: Article

References (46)

1. Brenchley JM, Price DA, Douek DC, (2006) HIV disease: fallout from a mucosal catastrophe? Nat Immunol 7: 235-239.
2. Lama J, Planelles V, (2007) Host factors influencing susceptibility to HIV infection and AIDS progression. Retrovirology 4: 52.
3. Moir S, Chun TW, Fauci AS, (2011) Pathogenic mechanisms of HIV disease. Annu Rev Pathol 6: 223-248.
4. Bosinger SE, Sodora DL, Silvestri G, (2011) Generalized immune activation and innate immune responses in simian immunodeficiency virus infection. Curr Opin HIV AIDS 6: 411-418.
5. Sodora DL, Allan JS, Apetrei C, Brenchley JM, Douek DC, et al. (2009) Toward an AIDS vaccine: lessons from natural simian immunodeficiency virus infections of African nonhuman primate hosts. Nat Med 15: 861-865.
6. Giorgi JV, Hultin LE, McKeating JA, Johnson TD, Owens B, et al. (1999) Shorter survival in advanced human immunodeficiency virus type 1 infection is more closely associated with T lymphocyte activation than with plasma virus burden or virus chemokine coreceptor usage. J Infect Dis 179: 859-870.
7. Barnabas RV, Webb EL, Weiss HA, Wasserheit JN, (2011) The role of coinfections in HIV epidemic trajectory and positive prevention: a systematic review and meta-analysis. AIDS 25: 1559-1573.
8. Kaul R, Cohen CR, Chege D, Yi TJ, Tharao W, et al. (2011) Biological factors that may contribute to regional and racial disparities in HIV prevalence. Am J Reprod Immunol 65: 317-324.
9. Walson JL, Herrin BR, John-Stewart G, (2009) Deworming helminth co-infected individuals for delaying HIV disease progression. Cochrane Database Syst Rev.
10. Heng MC, Heng SY, Allen SG, (1994) Co-infection and synergy of human immunodeficiency virus-1 and herpes simplex virus-1. Lancet 343: 255-258.
11. Reynolds SJ, Risbud AR, Shepherd ME, Zenilman JM, Brookmeyer RS, et al. (2003) Recent herpes simplex virus type 2 infection and the risk of human immunodeficiency virus type 1 acquisition in India. J Infect Dis 187: 1513-1521.
12. Sheth PM, Sunderji S, Shin LY, Rebbapragada A, Huibner S, et al. (2008) Coinfection with herpes simplex virus type 2 is associated with reduced HIV-specific T cell responses and systemic immune activation. J Infect Dis 197: 1394-1401.
13. Cohen CR, Moscicki AB, Scott ME, Ma Y, Shiboski S, et al. (2010) Increased levels of immune activation in the genital tract of healthy young women from sub-Saharan Africa. AIDS 24: 2069-2074.
14. McLaren PJ, Ball TB, Wachihi C, Jaoko W, Kelvin DJ, et al. (2010) HIV-exposed seronegative commercial sex workers show a quiescent phenotype in the CD4+ T cell compartment and reduced expression of HIV-dependent host factors. J Infect Dis 202: S339-344.
15. Pancino G, Saez-Cirion A, Scott-Algara D, Paul P, (2010) Natural resistance to HIV infection: lessons learned from HIV-exposed uninfected individuals. J Infect Dis 202: S345-350.
16. Kalinkovich A, Borkow G, Weisman Z, Tsimanis A, Stein M, et al. (2001) Increased CCR5 and CXCR4 expression in Ethiopians living in Israel: environmental and constitutive factors. Clin Immunol 100: 107-117.
17. Koesters SA, Matu L, Kiama P, Anzala O, Embree J, et al. (2004) Elevation of immune activation in kenyan women is associated with alterations in immune function: implications for vaccine development. J Clin Immunol 24: 702-709.
18. WHO (2011) TB Data 2011. Available: www.who.int/tb/data. Accessed 2012 Jun 25.
19. Berry MP, Graham CM, McNab FW, Xu Z, Bloch SA, et al. (2010) An interferon-inducible neutrophil-driven blood transcriptional signature in human tuberculosis. Nature 466: 973-977.
20. Jacobsen M, Repsilber D, Gutschmidt A, Neher A, Feldmann K, et al. (2007) Candidate biomarkers for discrimination between infection and disease caused by Mycobacterium tuberculosis. J Mol Med (Berl) 85: 613-621.
21. Alexandroff AB, Jackson AM, O'Donnell MA, James K, (1999) BCG immunotherapy of bladder cancer: 20 years on. Lancet 353: 1689-1694.
22. Croix DA, Capuano S, 3rd, Simpson L, Fallert BA, Fuller CL, et al (2000) Effect of mycobacterial infection on virus loads and disease progression in simian immunodeficiency virus-infected rhesus monkeys. AIDS Res Hum Retroviruses 16: 1895-1908.
23. Hanekom WA, (2005) The immune response to BCG vaccination of newborns. Ann N Y Acad Sci 1062: 69-78.
24. Huang D, Qiu L, Wang R, Lai X, Du G, et al. (2007) Immune gene networks of mycobacterial vaccine-elicited cellular responses and immunity. J Infect Dis 195: 55-69.
25. Toossi Z, Mayanja-Kizza H, Hirsch CS, Edmonds KL, Spahlinger T, et al. (2001) Impact of tuberculosis (TB) on HIV-1 activity in dually infected patients. Clin Exp Immunol 123: 233-238.
26. Prados-Rosales R, Baena A, Martinez LR, Luque-Garcia J, Kalscheuer R, et al. (2011) Mycobacteria release active membrane vesicles that modulate immune responses in a TLR2-dependent manner in mice. J Clin Invest 121: 1471-1483.
27. Equils O, Schito ML, Karahashi H, Madak Z, Yarali A, et al. (2003) Toll-like receptor 2 (TLR2) and TLR9 signaling results in HIV-long terminal repeat trans-activation and HIV replication in HIV-1 transgenic mouse spleen cells: implications of simultaneous activation of TLRs on HIV replication. J Immunol 170: 5159-5164.
28. Harding CV, Boom WH, (2010) Regulation of antigen presentation by Mycobacterium tuberculosis: a role for Toll-like receptors. Nat Rev Microbiol 8: 296-307.
29. Thoma-Uszynski S, Stenger S, Takeuchi O, Ochoa MT, Engele M, et al. (2001) Induction of direct antimicrobial activity through mammalian toll-like receptors. Science 291: 1544-1547.
30. van den Biggelaar AH, Prescott SL, Roponen M, Nadal-Sims MA, Devitt CJ, et al. (2009) Neonatal innate cytokine responses to BCG controlling T-cell development vary between populations. J Allergy Clin Immunol 124: 544-550, 550 e541-542.
31. Underhill DM, Ozinsky A, Smith KD, Aderem A, (1999) Toll-like receptor-2 mediates mycobacteria-induced proinflammatory signaling in macrophages. Proc Natl Acad Sci U S A 96: 14459-14463.
32. Page KR, Scott AL, Manabe YC, (2006) The expanding realm of heterologous immunity: friend or foe? Cell Microbiol 8: 185-196.
33. Sundstrom JB, Little DM, Villinger F, Ellis JE, Ansari AA, (2004) Signaling through Toll-like receptors triggers HIV-1 replication in latently infected mast cells. J Immunol 172: 4391-4401.
34. Thibault S, Fromentin R, Tardif MR, Tremblay MJ, (2009) TLR2 and TLR4 triggering exerts contrasting effects with regard to HIV-1 infection of human dendritic cells and subsequent virus transfer to CD4+ T cells. Retrovirology 6: 42.
35. Gonzalez OA, Li M, Ebersole JL, Huang CB, (2010) HIV-1 reactivation induced by the periodontal pathogens Fusobacterium nucleatum and Porphyromonas gingivalis involves Toll-like receptor 2 [corrected] and 9 activation in monocytes/macrophages. Clin Vaccine Immunol 17: 1417-1427.
36. Bafica A, Scanga CA, Schito ML, Hieny S, Sher A, (2003) Cutting edge: in vivo induction of integrated HIV-1 expression by mycobacteria is critically dependent on Toll-like receptor 2. J Immunol 171: 1123-1127.
37. Hernandez JC, Arteaga J, Paul S, Kumar A, Latz E, et al. (2011) Up-regulation of TLR2 and TLR4 in dendritic cells in response to HIV type 1 and coinfection with opportunistic pathogens. AIDS Res Hum Retroviruses 27: 1099-1109.
38. Bafica A, Scanga CA, Schito M, Chaussabel D, Sher A, (2004) Influence of coinfecting pathogens on HIV expression: evidence for a role of Toll-like receptors. J Immunol 172: 7229-7234.
39. Ogawa Y, Kawamura T, Kimura T, Ito M, Blauvelt A, et al. (2009) Gram-positive bacteria enhance HIV-1 susceptibility in Langerhans cells, but not in dendritic cells, via Toll-like receptor activation. Blood 113: 5157-5166.
40. Thibault S, Tardif MR, Barat C, Tremblay MJ, (2007) TLR2 signaling renders quiescent naive and memory CD4+ T cells more susceptible to productive infection with X4 and R5 HIV-type 1. J Immunol 179: 4357-4366.
41. Ding J, Rapista A, Teleshova N, Mosoyan G, Jarvis GA, et al. (2010) Neisseria gonorrhoeae enhances HIV-1 infection of primary resting CD4+ T cells through TLR2 activation. J Immunol 184: 2814-2824.
42. Ding J, Chang TL, (2012) TLR2 activation enhances HIV nuclear import and infection through T cell activation-independent and-dependent pathways. J Immunol 188: 992-1001.
43. Chang JS, Huggett JF, Dheda K, Kim LU, Zumla A, et al. (2006) Myobacterium tuberculosis induces selective up-regulation of TLRs in the mononuclear leukocytes of patients with active pulmonary tuberculosis. J Immunol 176: 3010-3018.
44. Schreiber HA, Harding JS, Hunt O, Altamirano CJ, Hulseberg PD, et al. (2011) Inflammatory dendritic cells migrate in and out of transplanted chronic mycobacterial granulomas in mice. J Clin Invest 121: 3902-3913.
45. Tan DB, Lim A, Yong YK, Ponnampalavanar S, Omar S, et al. (2011) TLR2-induced cytokine responses may characterize HIV-infected patients experiencing mycobacterial immune restoration disease. AIDS 25: 1455-1460.
46. Zhang H, Zhou Y, Alcock C, Kiefer T, Monie D, et al. (2004) Novel single-cell-level phenotypic assay for residual drug susceptibility and reduced replication capacity of drug-resistant human immunodeficiency virus type 1. J Virol 78: 1718-1729.